Heterogeneous nuclear ribonucleoprotein C promotes non-small cell lung cancer progression by enhancing XB130 mRNA stability and translation

被引:0
|
作者
Wang, Qinrong [1 ,2 ]
Gou, Xuanjing [1 ,2 ]
Liu, Lingling [1 ,2 ]
Deng, Daolan [1 ,2 ]
Zhao, Yan [1 ,2 ]
Zhou, Jianjiang [1 ,2 ]
Xie, Yuan [1 ,2 ]
Jiang, Yinhui [1 ,2 ]
Li, Jianglun [3 ]
Zhang, Jian [3 ]
Liu, Ying [1 ,2 ]
机构
[1] Guizhou Med Univ, Key Lab Endem & Ethn Dis, Minist Educ, 9 Beijing Rd, Guiyang 550004, Guizhou, Peoples R China
[2] Guizhou Med Univ, Key Lab Med Mol Biol Guizhou Prov, 9 Beijing Rd, Guiyang 550004, Guizhou, Peoples R China
[3] Guizhou Med Univ, Dept Thorac Surg, Affiliated Hosp, 28 Beijing Rd, Guiyang 550004, Guizhou, Peoples R China
基金
中国国家自然科学基金;
关键词
XB130; Non-small cell lung cancer; Heterogeneous nuclear ribonucleoprotein C; mRNA stability; Translation; ADAPTER PROTEIN; BINDING; INITIATION; MECHANISM;
D O I
10.1186/s12935-025-03638-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundXB130, a classical adaptor protein, exerts a critical role in diverse cellular processes. Aberrant expression of XB130 is closely associated with tumorigenesis and aggressiveness. However, the mechanisms governing its expression regulation remain poorly understood. Heterogeneous nuclear ribonucleoprotein C (hnRNPC), as an RNA-binding protein, is known to modulate multiple aspects of RNA metabolism and has been implicated in the pathogenesis of various cancers. We have previously discovered that hnRNPC is one of the candidate proteins that interact with the 3' untranslated region (3'UTR) of XB130 in non-small cell lung cancer (NSCLC). Therefore, this study aims to comprehensively elucidate how hnRNPC regulates the expression of XB130 in NSCLC.Materials and methodsWe evaluated the expression of hnRNPC in cancer and assessed the correlation between hnRNPC expression and prognosis in cancer patients using public databases. Subsequently, several stable cell lines were constructed. The proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) of these cells were detected through Real-time cellular analysis, adherent colony formation, wound healing assay, invasion assay, and Western blotting. The specific regulatory manner between hnRNPC and XB130 was investigated by Real-time quantitative PCR, Western blotting, RNA pull-down assay, dual-luciferase reporter assay, RNA immunoprecipitation, and Co-Immunoprecipitation.ResultsWe identified that hnRNPC expression is significantly elevated in NSCLC and correlates with poor prognosis in patients with lung adenocarcinoma. HnRNPC overexpression in NSCLC cells increased the expression of XB130, subsequently activating the PI3K/Akt signaling pathway and ultimately promoting cell proliferation and EMT. Additionally, overexpressing XB130 in hnRNPC-silenced cells partially restored cell proliferation and EMT. Mechanistically, hnRNPC specifically bound to the 3'UTR segments of XB130 mRNA, enhancing mRNA stability by inhibiting the recruitment of nucleases 5'-3' exoribonuclease 1 (XRN1) and DIS3-like 3'-5' exoribonuclease 2 (DIS3L2). Furthermore, hnRNPC simultaneously interacted with the eukaryotic initiation factor 4E (eIF4E), a component of the eIF4F complex, facilitating the circularization of XB130 mRNA and thereby increasing its translation efficiency.ConclusionsHnRNPC overexpression promotes NSCLC progression by enhancing XB130 mRNA stability and translation, suggesting that hnRNPC might be a potential therapeutic and prognostic target for NSCLC.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] The 3'-untranslated region of XB130 regulates its mRNA stability and translational efficiency in non-small cell lung cancer cells
    Wang, Qinrong
    Liu, Lingling
    Gou, Xuanjing
    Zhang, Ting
    Zhao, Yan
    Xie, Yuan
    Zhou, Jianjiang
    Liu, Ying
    Song, Kewei
    ONCOLOGY LETTERS, 2023, 26 (04)
  • [2] Prognostic expression of a novel adaptor protein XB130 in non-small cell lung cancer
    Lodyga, M
    Xhi, C
    Anraku, M
    Liu, N
    Tsao, M
    Liu, M
    Keshavjee, S
    LUNG CANCER, 2005, 49 : S135 - S135
  • [3] HNRNPC promotes progression of non-small cell lung cancer by maintaining TFAP2A mRNA stability
    Liao, Minghua
    Li, Chunyu
    Yang, Rui
    Li, Jun
    Wu, Ke
    Zhang, Jiayi
    Zhu, Qian
    Shi, Yingchang
    Zhang, Xianming
    CANCER CELL INTERNATIONAL, 2025, 25 (01)
  • [4] Has_circ_0002360 facilitates immune evasion by enhancing heterogeneous nuclear ribonucleoprotein A1 stability, thereby promoting malignant progression in non-small cell lung cancer
    Fan, Jun
    Xue, Lei
    Lu, Rongxin
    Liu, Jinyuan
    Luo, Jinhua
    EXPERIMENTAL CELL RESEARCH, 2024, 443 (02)
  • [5] TERC promotes non-small cell lung cancer progression by facilitating the nuclear localization of TERT
    Sun, Haohui
    Li, Xiaodi
    Long, Qian
    Wang, Xiaonan
    Zhu, Wancui
    Chen, Enni
    Zhou, Wenhao
    Yang, Han
    Huang, Chuyang
    Deng, Wuguo
    Chen, Miao
    ISCIENCE, 2024, 27 (06)
  • [6] Overexpression of Gremlin promotes non-small cell lung cancer progression
    Yin, Yunhong
    Yang, Yie
    Yang, Liyun
    Yang, Yan
    Li, Chunyu
    Liu, Xiao
    Qu, Yiqing
    TUMOR BIOLOGY, 2016, 37 (02) : 2597 - 2602
  • [7] Periostin promotes tumor progression in non-small cell lung cancer
    Okazaki, Toshimasa
    Tamai, Keiichi
    Shibuya, Rie
    Nakamura, Mao
    Mochizuki, Mai
    Yamaguchi, Kazunori
    Sato, Kenichi
    CANCER SCIENCE, 2018, 109 : 1105 - 1105
  • [8] Mitoregulin Promotes Cell Cycle Progression in Non-Small Cell Lung Cancer Cells
    Stein, Colleen S.
    Linzer, Connor R.
    Heer, Collin D.
    Witmer, Nathan H.
    Cochran, Jesse D.
    Spitz, Douglas R.
    Boudreau, Ryan L.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (05)
  • [9] FRS2 promotes the progression of non-small cell lung cancer
    Gao, Jingpeng
    Wang, Li
    Jiang, Yifei
    Qian, Juanjuan
    Mo, Weiqiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (02): : 758 - 765
  • [10] FTO-mediated autophagy inhibition promotes non-small cell lung cancer progression by reducing the stability of SESN2 mRNA
    Wang, Kai
    Mei, Zhiqiang
    Zheng, Meiling
    Liu, Xiaoyan
    Li, Dabing
    Wang, Haiyong
    HELIYON, 2024, 10 (05)